AusPAR: Bevacizumab (rch)

Australian Public Assessment Report

AusPAR

AusPAR: Bevacizumab (rch) [PDF, 1.12 MB]

AusPAR: Bevacizumab (rch) [Word, 1.89 MB]

Attachment: Product Information: Bevacizumab (rch) [PDF, 642.5 KB]

Attachment: Product Information: Bevacizumab (rch) [Word, 408.51 KB]

Attachment: Extract from Clinical Evaluation Report: Bevacizumab (rch) [PDF, 2.3 MB]

Attachment: Extract from Clinical Evaluation Report: Bevacizumab (rch) [Word, 4.32 MB]

Device/Product Name

Avastin

Active ingredients

Bevacizumab (rch)

AusPAR Date

10 May 2017

Published

25 May 2017

Submission Number

PM-2014-01871-1-4

Submission Type

Major variation (new indication)

Decision

Approved